India's Bajaj Healthcare forays into opiate processing
13/07/2022 05:09
BENGALURU, July 13 (Reuters) - Indian pharmaceutical company Bajaj Healthcare Ltd BAJH.NS said on Wednesday it was entering the highly-regulated opiate processing business after winning two tenders from the government. (Reporting by Chris Thomas in Bengaluru; Editing by Rashmi Aich) ((chris.thomas@thomsonreuters.com; +91-80-6749-8695;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees